Jonathan A. Sugam

Merck & Co., Inc., Rahway, NJ, USA (United States)

Neuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Mu Opioid Receptor Modulation of Dopamine Neurons in the Periaqueductal Gray/Dorsal Raphe: A Role in Regulation of Pain”.

Mu Opioid Receptor Modulation of Dopamine Neurons in the Periaqueductal Gray/Dorsal Raphe: A Role in Regulation of Pain

UNC Libraries(2020)10.17615/mt0x-cp42

N/A

0DataRank · unranked

7 citations

Alberto J. López, Nora M. McCall, Jessica M. McKlveen, Thomas L. Kash, Emily G. Lowery‐Gionta +4 more

Serotonin modulates an inhibitory input to the central amygdala from the ventral periaqueductal gray

Neuropsychopharmacology(2022)10.1038/s41386-022-01392-4

N/A

0DataRank · unranked

25 citations

Jeffrey F. DiBerto, Christopher M. Mazzone, Jonathan A. Sugam, Daniel W. Bloodgood, J. Andrew Hardaway +7 more

Serotonin Modulates an Inhibitory Input to the Central Amygdala from the Ventral Periaqueductal Gray

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.28.486055

N/A

0DataRank · unranked

2 citations

Jeffrey F. DiBerto, Christopher M. Mazzone, Jonathan A. Sugam, Daniel W. Bloodgood, J. Andrew Hardaway +7 more